Home LiteratureArticle Details
PMID: 4035354 Published · ppublish English Journal Article

Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines.

Science (New York, N.Y.) ·Vol. 229 ·No. 4719 ·1985-09-20 ·Pages 1265-8

Curran T, Morgan JI

Abstract

Alterations in proto-oncogene expression after stimulation of rat pheochromocytoma (PC12) cells by nerve growth factor (NGF) have been investigated. A specific stimulation of c-fos messenger RNA and protein was detected 30 minutes after treatment. This induction was enhanced more than 100-fold in the presence of peripherally active benzodiazepines. The effect was specific as very little change was observed in the levels of c-rasHa, c-rasKi, c-myc, and N-myc messenger RNA's. Under the conditions used here, NGF treatment ultimately results in neurite outgrowth, with a reduction or cessation of cell division. Thus, stimulation of the c-fos gene in this system appeared to be associated with differentiation and not with cellular proliferation. The effect of benzodiazepines was stereospecific and represents a novel action of these compounds at the level of gene expression.

MeSH Terms
Animals Benzodiazepines/pharmacology Cell Line Cell Transformation, Neoplastic/drug effects Gene Expression Regulation/drug effects Nerve Growth Factors/pharmacology Oncogenes Pheochromocytoma/genetics,metabolism RNA, Messenger/biosynthesis Rats
Chemicals
Nerve Growth Factors RNA, Messenger Benzodiazepines
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Curran T
Morgan J I
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1985-09-20
Pages
1265-8
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com